Anal Fissure Treatment Market Research Report - Global Forecast till 2027

Anal Fissure Treatment Market Research Report: Information, by Treatment Type (Medication and Surgery), Route of Administration (Oral and Topical), End User (Hospitals & Clinics and Research & Academic institutes) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/2553-CR | August 2019 | Region: Global | 101 pages

The Anal Fissure Treatment Market is expected to register 7.6% CAGR and is expected to reach USD 2,526.5 Million by 2023.


An anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The prominent factors that drive the market growth are growing incidences of constipation, a rapidly growing aging population, and increasing adoption of an unhealthy lifestyle. However, the popularity of over the counter (OTD) drugs and alternative treatment therapies for anal fissure are likely to restrain the market growth over the forecast period.


Market Dynamics


Constipation is a condition where the individual might have stools that are difficult or painful to pass being hard, dry, or lumpy. However, long-lasting constipation may have complications, such as hemorrhoids, anal fissures, rectal prolapse, and others. According to a recent survey by the American Gastroenterological Association, 16% of Americans suffer from chronic constipation, and nearly 33% over the age of 60 experience the condition. This leads to almost 6 million visits to the doctors’ offices or clinics and nearly 700,000 visits to emergency rooms every year.


Furthermore, according to the survey conducted by IPSOS, a market research firm, and Abbott India in 2018, 22% of the adult Indian population suffer from constipation, with 13% complaining of severe constipation. However, when the same survey was conducted by Abbott India and IPSOS in 2015, which found that 14% people in urban India suffer from chronic constipation and incidents of chronic constipation was over 10% worldwide. Thus, the growing incidences of constipation related problems worldwide are driving the growth of anal fissure treatment market.


Anal Fissure Treatment Market Revenue, by Treatment, 2017 (USD Million)  Anal Fissure Treatment Market


Sources: MRFR Analysis


Segmentation


The anal fissure treatment market is segmented into treatment type, route of administration, end user, and region.


Based on treatment, the anal fissure treatment market is divided into medication and surgery. The medication segment is further segmented into stool softeners, laxatives, anesthetics and steroids, nitroglycerin, calcium channel blocking drugs, and botulinum toxin. Topical agents such as nitroglycerin ointments or calcium channel blockers including diltiazem or nifedipine that relax the internal anal sphincter and increase blood flow to the affected area have been proven in randomized placebo-controlled trials to be effective in reducing the healing time with success rates.


Based on route of administration, the global market is divided in to oral and topical. In oral administration, the medicine or drug is taken through the mouth. The oral treatment methods for anal fissure include pain-relieving drugs and calcium channel blockers, which include LOMOTIL and Tribenzo drugs. Companies such as Teva Pharmaceutical Industries Ltd, Pfizer Inc., and Allergan Inc. offer oral drugs for anal fissure treatment.


Based on end user, the global market is divided into Hospitals & Clinics and Research & Academic institutes. The hospitals & clinics segment held the largest market share in the anal fissure treatment market in 2017. The increasing number of patients with diarrhea, constipation, and Crohn's disease is expected to drive this segment in the global market during the forecast period.


Anal Fissure Treatment Market Share, by Region, 2017 (%)    Anal Fissure Treatment Market      


Sources: MRFR Analysis


Regional Analysis


Based on region, the anal fissure treatment market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


The Americas is expected to reach USD 1,000.6 million by 2023 with 7.8% CAGR from 2018 to 2023. The region accounts for the largest regional market owing to the growing geriatric population, childbirth trauma in women, increasing Crohn's disease, and ulcerative colitis among the population. According to the Centers for Disease Control and Prevention, it was estimated that three million adults in the US were reported to be diagnosed with inflammatory bowel disease in 2015. The growing inflammatory bowel disease in the Americas is likely to increase the demand for anal fissure treatment in this region.


Europe is anticipated to hold the second-largest market for anal fissure treatment during the forecast period. The increasing consumption of fast food and improper eating habits are creating intestinal problems in the population. Additionally, some food allergies are also responsible for causing immune system problems, diarrhea or chronic constipation that would increase the demand for anal fissure treatment products. According to the United Nations International Children's Emergency Fund (UNICEF) data, worldwide 480,000 young children are dying every year due to diarrhea. The increasing prevalence of diarrhea among children may increase the demand for anal fissure treatment.


The presence of several major pharmaceutical and biotech companies in Asia-Pacific that are introducing new products and treatment methods for anal fissure treatment is expected to boost the market in the region during the forecast period.


The Middle East & Africa holds the least market share. Factors such as rising health problems including frequent diarrhea or chronic constipation caused due to poor nutrition support and consumption of contaminated drinking water are causing anal fissures among the population. The increasing awareness about treatments and products for treating an anal fissure is expected to boost the market growth in the region during the forecast period.


Key Players


Pfizer Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Cook, Cigna, Eisai Co. Ltd, Abbott Laboratories, Bayer AG, AstraZeneca, Allergan Inc., Valeant Pharmaceuticals International Inc., and Taro Pharmaceutical Industries Ltd are some of the major players operating in the anal fissure treatment market.


The players operating in the anal fissure treatment market are focusing on product launches, along with expanding their global footprints by entering untapped markets.  


Market Segmentation


Anal Fissure Treatment Market, by Treatment Type



  • Medication

  • Surgery


Anal Fissure Treatment Market, by Routes of Administration



  • Oral

  • Topical


Anal Fissure Treatment Market, by End User



  • Hospitals & Clinics

  • Research & Academic institutes


Anal Fissure Treatment Market, by Region



  • North America


    • US

    • Canada

    • Mexico




  • Europe


    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe




  • Asia-Pacific


    • China

    • India

    • Japan

    • Australia & New Zealand

    • Southeast Asia

    • Rest of Asia-Pacific




  • Rest of the World


    • Middle East

    • Africa

    • South America



Intended Audience



  • Medical research laboratories

  • Medical device manufacturers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Potential investors



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 2,526.5 Million
  CAGR   7.6% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Treatment Type, Route of Administration, End User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Pfizer Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Cook, Cigna, Eisai Co. Ltd, Abbott Laboratories, Bayer AG, AstraZeneca, Allergan Inc., Valeant Pharmaceuticals International Inc., and Taro Pharmaceutical Industries Ltd
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions, new product developments
  Key Market Drivers

  • Growing incidences of constipation
  • Rapidly growing aging population


  • Frequently Asked Questions (FAQ) :


    Anal fissure treatment market projected to grow at approximately 7.6% CAGR during the assessment period (2018-2023).

    The valuation of the global anal fissure treatment market is estimated to increase to USD 2,526.5 MN by the end of 2023.

    Advances in technology and the availability of various treatment options are major tailwinds pushing the growth of the global anal fissure treatment market.

    North America holds the largest share in the global anal fissure treatment market, followed by Europe and the Asia Pacific, respectively.

    Abbott Laboratories (U.S.), AstraZeneca (U.K.), Pfizer Inc. (U.S.), Eisai Co. Ltd. (Japan), GlaxoSmithKline Plc (U.K.), Cigna (U.S.), Taro Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Allergan Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Valeant Pharmaceuticals International Inc. (Canada), and Cook (U.S.), are some of the top players operating in the global anal fissure treatment market.

    Anal Fissure Treatment Market – Report Summary


    Global anal fissure treatment market to post a compound annual growth rate of 7.6% during the forecast period (2018-2023). The incidence rate has increased to a significant extent in recent years. The expanding patient population is driving the demand for anal fissure treatment. The onset of anal fissure is primarily linked with conditions such as constipation, diarrhea, Crohn's disease etc. Fissure could be a minor or major tear in the mucosal lining of the distal anal canal below the dentate line. Unhealthy eating habits and constipation are some of the factors associated with anal fissure.


    There is a strong demand for anal fissure medication. The condition occurs in both minors and adults. Various over-the-counter medicines for anal fissure have come up in recent years. At the same time, alternative treatment therapies are available as well. The rising geriatric population is expected to reflect favorably on the global anal fissure treatment market during the forecast period. ¬Strain while passing the stool is a common issue in elderly population, this often result in anal fissure. Elderly people and infants are more susceptible to such conditions owing to the higher fragility. Currently, over-the-counter medications are witnessing a strong demand as most individuals are inclined towards such convenient options. Topical nitroglycerin and calcium channel blockers such as nifedipine and diltiazem are the first line of treatment for symptomatic anal fissure.


    Segmental Analysis


    Segmental analysis of the global anal fissure treatment market has been conducted on the basis of treatment type, route of administration, end user and region.


    By treatment type, the market has been segmented into medications and surgery.  The medication segment is further segmented into stool softeners, laxatives, anesthetics and steroids, nitroglycerin, calcium channel blocking drugs, and botulinum toxin. Currently, the medication segment accounts of the largest market share in terms of value. In 2017, the segment accounted for more than two-third share of the market and is set to exhibit a CAGR of 7.68% during the forecast period.


    On the basis of administration, the market has been segmented into oral, topical and others. The oral segment is expected to remain highly lucrative during the forecast period. The segment accounted for 78.35% share of the market in 2017 and is expected to reach USD 2,004.2 Mn by 2023, reflecting a healthy CAGR. Some of the common oral treatment methods for anal fissure include pain-relieving drugs and calcium channel blockers namely LOMOTIL and Tribenzo drugs.


    Based on end user, the market has been segmented into hospitals and clinics, academic and research institutes, and others. In terms of value, the hospitals and clinics segment accounts for the lion’s share of the market. This is primarily attributed to factors such as growing patient influx in hospitals and rapid development of healthcare infrastructure in developing countries. Towards the end of the assessment period, the healthcare and clinic segment is likely to reach a market valuation of USD 1,717.1 Mn by 2023.


    Regional Analysis


    On the basis of region, the global anal fissure market has been segmented into Americas, Europe, Asia-Pacific, and the Middle East and Africa. Of these, the market in Americas is highly attractive. During the forecast period, the market in the region is expected to surge at 7.8% CAGR to reach a valuation of over 1,000 Mn. Growing geriatric population, strong healthcare penetration and increased prevalence of associated disorders such as Crohn's disease, inflammatory bowel disease and ulcerative colitis is are factors influencing the incidence rate in countries such as the U.S, Canada, Mexico and Brazil.


    Meanwhile, Europe holds the second spot and is likely to retain its position over the forecast period. Existence of robust healthcare facilities, especially in West Europe coupled with the high healthcare expenditure supports the growth of the market in the region. Also, the region geriatric population in many of the European countries such as the U.K., France, Germany, among others is influencing the incidence rate in Europe. Asia Pacific is also emerging as a significant market for anal fissure treatment. High rate of diarrhea, consumption of unhealthy food and improving healthcare penetration of healthcare are some of factors influence the market’s growth in the region. The market is Asia-Pacific is expected to register a CAGR of 7.9% during the forecast period. Many of the global pharmaceutical and biotech companies are expanding their operations in APAC in order to tap into lucrative opportunities present in the region.


    Competition Tracking


    Prominent players in the anal fissure treatment market report include GlaxoSmithKline Plc (U.K.), Valeant Pharmaceuticals International Inc (Canada), Cigna (U.S.), Allergan Inc. (U.S.), Eisai Co. Ltd. (Japan), Abbott Laboratories (U.S.), AstraZeneca (U.K.), Cook (U.S.), Pfizer Inc. (U.S.), Taro Pharmaceutical Industries Ltd. (Israel), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), and others.  

    1 Report Prologue

    2 Market Introduction

    2.1 Scope of Study 14

    2.2 Research Objective 14

    2.3 List of Assumptions 14

    3 Research Methodology

    3.1 Research Process 17

    3.2 Primary Research 18

    3.3 Secondary Research 19

    3.4 Market Size Estimation 20

    4 Market Dynamic

    4.1 Introduction 22

    4.2 Drivers 23

    4.2.1 Increasing Pediatric and Geriatric Population 23

    4.2.2 Growing Incidences of Constipation 23

    4.2.3 Increasing Adoption of Unhealthy Lifestyle 23

    4.2.4 Popularity of Over-the-Counter (OTD) Drugs 23

    4.3 Restraints 24

    4.3.1 Alternate Treatment Therapies 24

    4.3.2 Declining Reimbursements 24

    4.4 Opportunities 24

    4.4.1 Entering Untapped Markets 24

    5 Market Factor Analysis

    5.1 Porter’s Five Forces Analysis 26

    5.1.1 Bargaining Power of Suppliers 26

    5.1.2 Bargaining Power of Buyers 27

    5.1.3 Threat of New Entrants 27

    5.1.4 Threat of Substitutes 27

    5.1.5 Intensity of Rivalry 27

    5.2 Value Chain Analysis 28

    5.2.1 Primary Activities 28

    5.2.2 Secondary Activities 28

    6 Anal Fissure Treatment Market, by Treatment Type

    6.1 Introduction 30

    6.2 Medication 31

    6.3 Surgery 32

    7 Anal Fissure Treatment Market, by Route of Administration

    7.1 Introduction 34

    7.2 Oral 35

    7.3 Topical 36

    8 Anal Fissure Treatment Market, by End User

    8.1 Introduction 38

    8.2 Hospitals & Clinics 39

    8.3 Research & Academic institutes 39

    9 Global Anal Fissure Treatment Market, by Region

    9.1 Introduction 41

    9.2 Americas 43

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.2.1 North America 45

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.2.1.1 US 47

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.2.1.2 Canada 48

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.2.2 South America 49

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3 Europe 50

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.1 Western Europe 52

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.1.1 Germany 54

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.1.2 UK 55

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.1.3 France 56

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.1.4 Italy 57

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.1.5 Spain 58

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.1.6 Rest of Western Europe 59

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.3.2 Eastern Europe 60

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.4 Asia-Pacific 62

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.4.1 Japan 64

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.4.2 China 65

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.4.3 India 66

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.4.4 Australia 67

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.4.5 South Korea 68

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.4.6 Rest of Asia-Pacific 69

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    9.5 Rest of the World 71

    Anal Fissure Treatment Market, by Treatment Type

    Anal Fissure Treatment Market, by Route of Administration

    Anal Fissure Treatment Market, by End User

    10 Competitive Landscape

    10.1 Introduction 73

    11 Company Profiles

    11.1 Pfizer Inc. 75

    11.1.1 Company Overview 75

    11.1.2 Financial Overview 75

    11.1.3 Products/Services Offered 76

    11.1.4 Key Developments 76

    11.1.5 SWOT Analysis 76

    11.1.6 Key Strategies 76

    11.2 Teva Pharmaceutical Industries Ltd 77

    11.2.1 Company Overview 77

    11.2.2 Financial Overview 77

    11.2.3 Products/Services Offered 78

    11.2.4 Key Developments 78

    11.2.5 SWOT Analysis 78

    11.2.6 Key Strategies 78

    11.3 GlaxoSmithKline Plc 79

    11.3.1 Company Overview 79

    11.3.2 Financial Overview 79

    11.3.3 Products/Services Offered 80

    11.3.4 Key Developments 80

    11.3.5 SWOT Analysis 80

    11.3.6 Key Strategies 80

    11.4 Cook 81

    11.4.1 Company Overview 81

    11.4.2 Financial Overview 81

    11.4.3 Products/Services Offered 81

    11.4.4 SWOT Analysis 81

    11.4.5 Key Developments 81

    11.4.6 Key Strategies 81


    11.5 Cigna 82

    11.5.1 Company Overview 82

    11.5.2 Financial Overview 82

    11.5.3 Products/Services Offered 83

    11.5.4 SWOT Analysis 83

    11.5.5 Key Developments 83

    11.5.6 Key strategy 83

    11.6 Eisai Co. Ltd. 84

    11.6.1 Company Overview 84

    11.6.2 Financial Overview 84

    11.6.3 Products/Services Offered 85

    11.6.4 Key Developments 85

    11.6.5 SWOT Analysis 85

    11.6.6 Key Strategies 85

    11.7 Abbott Laboratories 86

    11.7.1 Company Overview 86

    11.7.2 Financial Overview 86

    11.7.3 Products/Services Offered 87

    11.7.4 Key Developments 87

    11.7.5 SWOT Analysis 87

    11.7.6 Key strategy 88

    11.8 Bayer AG 89

    11.8.1 Company Overview 89

    11.8.2 Financial Overview 89

    11.8.3 Products/Services Offered 90

    11.8.4 Key Developments 90

    11.8.5 SWOT Analysis 90

    11.8.6 Key Strategies 90

    11.9 AstraZeneca 91

    11.9.1 Company Overview 91

    11.9.2 Financial Overview 91

    11.9.3 Products/Services Offered 92

    11.9.4 Key Developments 92

    11.9.5 SWOT Analysis 92

    11.9.6 Key Strategies 92

    11.10 Allergan Inc. 93

    11.10.1 Company Overview 93

    11.10.2 Financial Overview 93

    11.10.3 Products/Services Offered 94

    11.10.4 Key Developments 94

    11.10.5 SWOT Analysis 94

    11.10.6 Key Strategies 94

    11.11 Valeant Pharmaceuticals International Inc. 95

    11.11.1 Company Overview 95

    11.11.2 Financial Overview 95

    11.11.3 Products/Services Offered 96

    11.11.4 Key Developments 96

    11.11.5 SWOT Analysis 96

    11.11.6 Key Strategies 96

    11.12 Taro Pharmaceutical Industries Ltd 97

    11.12.1 Company Overview 97

    11.12.2 Financial Overview 97

    11.12.3 Products/Services Offered 98

    11.12.4 Key Developments 98

    11.12.5 SWOT Analysis 98

    11.12.6 Key Strategies 98

    12 Appendix

    12.1 Discussion Blue Print 100

    13 List of Tables

    TABLE 1 LIST OF ASSUMPTIONS 14

    TABLE 2 PRIMARY INTERVIEWS 17

    TABLE 3 GLOBAL ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 30

    TABLE 4 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR MEDICATION 2020–2027 (USD MILLION) 31

    TABLE 5 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR SURGERY 2020–2027 (USD MILLION) 32

    TABLE 6 GLOBAL ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 34

    TABLE 7 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR ORAL 2020–2027 (USD MILLION) 35

    TABLE 8 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR TOPICAL 2020–2027 (USD MILLION) 36

    TABLE 9 GLOBAL ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 38

    TABLE 10 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR HOSPITALS & CLINICS 2020–2027 (USD MILLION) 39

    TABLE 11 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR HOSPITALS & CLINICS 2020–2027 (USD MILLION) 39

    TABLE 12 GLOBAL ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 41

    TABLE 13 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 43

    TABLE 14 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 43

    TABLE 15 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 44

    TABLE 16 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 44

    TABLE 17 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY COUNTRY 2020–2027 (USD MILLION) 45

    TABLE 18 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 45

    TABLE 19 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 46

    TABLE 20 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 46

    TABLE 21 US ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 47

    TABLE 22 US: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 47

    TABLE 23 US: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 47

    TABLE 24 CANADA ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 48

    TABLE 25 CANADA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 48

    TABLE 26 CANADA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 48

    TABLE 27 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 49

    TABLE 28 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 49

    TABLE 29 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 49

    TABLE 30 EUROPE: ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 50

    TABLE 31 EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 50

    TABLE 32 EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 51

    TABLE 33 EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 51

    TABLE 34 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY COUNTRY/REGION 2020–2027 (USD MILLION) 52

    TABLE 35 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 53

    TABLE 36 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 53

    TABLE 37 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 53

    TABLE 38 GERMANY: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 54

    TABLE 39 GERMANY: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 54

    TABLE 40 GERMANY: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 54

    TABLE 41 UK: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 55

    TABLE 42 UK: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 55

    TABLE 43 UK: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 55

    TABLE 44 FRANCE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 56

    TABLE 45 FRANCE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 56

    TABLE 46 FRANCE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 56

    TABLE 47 ITALY: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 57

    TABLE 48 ITALY: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 57

    TABLE 49 ITALY: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 57

    TABLE 50 SPAIN: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 58

    TABLE 51 SPAIN: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 58

    TABLE 52 SPAIN: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 58

    TABLE 53 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 59

    TABLE 54 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

    2020–2027 (USD MILLION) 59

    TABLE 55 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 60

    TABLE 56 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 60

    TABLE 57 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 60

    TABLE 58 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 61

    TABLE 59 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY COUNTRY/REGION 2020–2027 (USD MILLION) 62

    TABLE 60 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 63

    TABLE 61 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 63

    TABLE 62 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 63

    TABLE 63 JAPAN: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 64

    TABLE 64 JAPAN: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 64

    TABLE 65 JAPAN: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 64

    TABLE 66 CHINA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 65

    TABLE 67 CHINA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 65

    TABLE 68 CHINA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 65

    TABLE 69 INDIA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 66

    TABLE 70 INDIA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 66

    TABLE 71 INDIA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 66

    TABLE 72 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 67

    TABLE 73 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 67

    TABLE 74 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 67

    TABLE 75 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 68

    TABLE 76 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 68

    TABLE 77 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 68

    TABLE 78 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 69

    TABLE 79 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 69

    TABLE 80 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 70

    TABLE 81 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 71

    TABLE 82 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 71

    TABLE 83 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 71

    TABLE 84 TOP PLAYERS IN THE GLOBAL ANAL FISSURE TREATMENT MARKET 73

    14 List of Figures

    FIGURE 1 GLOBAL ANAL FISSURE TREATMENT MARKET: MARKET STRUCTURE 15

    FIGURE 2 RESEARCH PROCESS 17

    FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 20

    FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ANAL FISSURE TREATMENT MARKET 22

    FIGURE 5 VALUE CHAIN 28

    FIGURE 6 GLOBAL ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020 & 2027 (USD MILLION) 31

    FIGURE 7 GLOBAL ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020 & 2027 (USD MILLION) 35

    FIGURE 8 GLOBAL ANAL FISSURE TREATMENT MARKET, BY END USER 2020 & 2027 (USD MILLION) 38

    FIGURE 9 GLOBAL ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 42

    FIGURE 10 AMERICAS: ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 43

    FIGURE 11 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY 2020 (%) 45

    FIGURE 12 EUROPE: ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 50

    FIGURE 13 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY/REGION 2020 (%) 52

    FIGURE 14 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY/REGION 2020 (%) 62

    Global Anal Fissure Treatment Market: Competitive Landscape


    The global anal fissure treatment market is characterized by the presence of many global, regional, and local players. The market is competitive with all players competing to gain a presence in the market. Intense competition, rapid advances in technology, frequent changes in government policies, and regulations are key factors that confront market growth. The manufacturers compete based on cost, quality, and reliability. It is decisive for manufacturers to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.


    The growth of market players is dependent on market conditions, government support, and industry development. Thus, manufacturers should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players are likely to strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that the improvement of the global economic scenario combined with efforts to enhance the infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new products and increase the global market share.


    The players with better technical and financial resources could develop innovative products. Further, research and development would play a major role in the development of players in the market. Therefore, manufacturers must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their products and services in the market.